Glysolin 30/70 Special Precautions

Switching to different type of insulin: If you are switching to another type of insulin, it should be done under strict supervision. Changes in strength, brand (manufacturer), type (rapid acting insulin, intermediate acting insulin, long acting insulin, etc), species (animal, insulin human analog) and/or method of manufacture (recombinant versus animal source insulin) may result in the need for a change in dose. Patients switching to (Glysolin 30/70) may require a change in dosage form that used with their usual insulin.
Laboratory Tests: As with all insulins, the therapeutic response to human insulin should be monitored by periodic blood glucose tests. Periodic measurement of glycosylated hemoglobin is recommended for the monitoring of long-term glycemic control.
Effects on the ability to drive and use machines: The patient's ability to concentrate and react may be impaired as a result of hypoglycemia. This may constitute a risk in situations where those abilities are of special importance (e.g. driving a car or operating machinery). You are therefore advised to avoid hypoglycemia during driving. This is particularly significant in patients who have reduced awareness of the warning signs of hypoglycemia or have frequent episodes of hypoglycemia.
Use in Pregnancy: There are no restrictions on the use of insulin during pregnancy since insulin does not cross the placental barrier.
Published studies with human insulin suggest that optimizing overall glycemic control, including postprandial control, before conception and during pregnancy improves fetal outcome. Although fetal complications of maternal hyperglycemia have been well documented, fetal toxicity also has been reported with maternal hypoglycemia. Insulin requirements usually fall during the first trimester and increase during the second and third trimesters.
During perinatal period, careful monitoring of infants born to mothers with diabetes is warranted.
Use in Lactation: There are no restrictions on the use of insulin in lactating mothers as insulin treatment of nursing mothers does not involve any risk to the baby. However, caution should be exercised when administered to nursing mothers and the dosage of insulin may be reduced.